Friday, October 29, 2021
Home Tags Lupin Limited

Tag: Lupin Limited

Lupin gets USFDA nod for generic Antifungal drug

Global pharma major Lupin Limited announced the US launch of tavaborole topical solution, 5% having received an approval from the United States...

Lupin launches generic drug to treat HIV 1 infection

Global pharma major Lupin Limited announced the launch of emtricitabine and tenofovir disoproxil fumarate tablets 200 mg/300 mg, having received an approval...

Lupin gets USFDA nod for treatment of Kidney patient

Global pharma major Lupin Limited announced that it has received approval for its sevelamer hydrochloride tablets, 400 mg and 800 mg from...

Lupin launches generic Nitazoxanide tablets

Global pharma major, Lupin Limited announced the launch of the authorized generic version of Alinia (nitazoxanide) tablets, 500 mg of Romark Laboratories,...

Lupin launches generic Penicillamine tablets

Global pharma major Lupin Limited announced the launch of the United States Food and Drug Administration (USFDA) approved penicillamine tablets USP, 250...

Lupin receives EIR from USFDA

Lupin Limited announced the receipt of the Establishment Inspection Report (EIR) after closure of the US FDA inspection of its Mandideep unit...

Latest posts

Sun Pharma launches drug to treat Plaque Psoriasis in Canada

Homegrown pharma major Sun Pharmaceutical Industries Ltd said it has launched its medicine ILUMYA. This drug is used in...

Authors

52 POSTS0 COMMENTS
30 POSTS0 COMMENTS
17 POSTS0 COMMENTS
15 POSTS0 COMMENTS
11 POSTS0 COMMENTS
9 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS